SI-27, A Novel Inhibitor of Matrix Metalloproteinases with Antiangiogenic Activity: Detection with a Variable-pressure Scanning Electron Microscope
Authors:
- 1 March 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 50 (3) , 578-587
Abstract
Degradation of basement membrane is one the of crucial steps in tumor angiogenesis and is performed by matrix metalloproteinases (MMPs). This study was designed to investigate the suppression of tumor angiogenesis by SI-27, an MMP inhibitor. SI-27 was applied at noncytotoxic concentrations (1–100 μmol/L), and its effect on nonmitogenic vascular endothelial growth factor (VEGF)-enhanced cell motility and in vitro angiogenesis by human umbilical vein endothelial cells was determined. The activity of MMP-1, MMP-2, and tissue inhibitor of metalloproteinase 1 was determined by enzyme-linked immunosorbent assay. The effect of SI-27 on in vitro angiogenesis stimulated by supernatants of human glioma cell lines (U87MG, U251MG, and U373MG) also was examined. Angiogenesis was detected with variable vacuum scanning electron microscopy. Cell motility and in vitro angiogenesis by human umbilical vein endothelial cells were significantly increased by VEGF. The maximal effect on cell motility by VEGF was noted at 5 ng/ml (P < 0.001), and the maximal effect on the capillary network was observed at 10 ng/ml (P < 0.001), along with elevated MMP-1 and MMP-2 activity. Whereas SI-27 significantly suppressed VEGF-mediated in vitro angiogenesis (50 μmol/L;P < 0.001) and inactivated both MMP-1 and MMP-2, the expression of tissue inhibitor of metalloproteinase 1 and VEGF-mediated cell motility were not affected by SI-27. The angiogenesis promoted by glioma supernatants showed a significant reduction in the presence of SI-27 (10 μmol/L; U87MG, P < 0.01; U251MG, P < 0.01; U373MG, P < 0.01). SI-27 inhibited in vitro tumor angiogenesis by suppression of MMP. This agent may be anticipated to prevent tumor growth through an angiosuppressive effect.Keywords
This publication has 37 references indexed in Scilit:
- Expression of Matrix Metalloproteinase-2 (MMP-2) and Vascular Endothelial Growth Factor (VEGF) in Inflammation-associated Corneal NeovascularizationExperimental Eye Research, 2000
- Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomasBritish Journal of Cancer, 1999
- Vascularization of human glioma spheroids implanted into rat cortex is conferred by two distinct mechanismsJournal of Neuroscience Research, 1999
- ENDOTHELIAL CELL RESPONSES TO HYPOXIC STRESSClinical and Experimental Pharmacology and Physiology, 1999
- Relationship between matrix metalloproteinase expression and tumor angiogenesis in human breast carcinoma.Oncology Reports, 1998
- Regulation of distinct steps of angiogenesis by different angiogenic molecules.International Journal of Oncology, 1998
- Direct Observation of t-Butyl Alcohol Frozen and Sublimated Samples Using Low-Vacuum Scanning Electron Microscopy.Archives of Histology and Cytology, 1998
- Human microvascular endothelial cells differ from macrovascular endothelial cells in their expression of matrix metalloproteinasesThe International Journal of Biochemistry & Cell Biology, 1997
- Induction of vascular endothelial tubular morphogenesis by human glioma cells. A model system for tumor angiogenesis.Journal of Clinical Investigation, 1993
- Matrix Metalloproteinases: A ReviewCritical Reviews in Oral Biology & Medicine, 1993